M. Martin, V. Atallah, S. Prey, E. Gérard, F. Amestoy, N. Benziane, N. Leduc, A. Huchet, M. Beylot-Barry, C. Dupin, O. Nora, C. Dutriaux, R. Trouette, L. Dousset, V. Vendrely
{"title":"靶向治疗后B-RAF突变黑色素瘤免疫治疗患者的并发放疗:114例患者的单中心比较研究","authors":"M. Martin, V. Atallah, S. Prey, E. Gérard, F. Amestoy, N. Benziane, N. Leduc, A. Huchet, M. Beylot-Barry, C. Dupin, O. Nora, C. Dutriaux, R. Trouette, L. Dousset, V. Vendrely","doi":"10.1016/j.canrad.2019.07.061","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":414877,"journal":{"name":"Cancer/Radiothérapie","volume":"45 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radiothérapie concomitante chez des patients pris en charge par immunothérapie pour mélanome avec mutation de B-RAF après thérapie ciblée : étude monocentrique comparative sur 114 patients\",\"authors\":\"M. Martin, V. Atallah, S. Prey, E. Gérard, F. Amestoy, N. Benziane, N. Leduc, A. Huchet, M. Beylot-Barry, C. Dupin, O. Nora, C. Dutriaux, R. Trouette, L. Dousset, V. Vendrely\",\"doi\":\"10.1016/j.canrad.2019.07.061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":414877,\"journal\":{\"name\":\"Cancer/Radiothérapie\",\"volume\":\"45 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer/Radiothérapie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.canrad.2019.07.061\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer/Radiothérapie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.canrad.2019.07.061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Radiothérapie concomitante chez des patients pris en charge par immunothérapie pour mélanome avec mutation de B-RAF après thérapie ciblée : étude monocentrique comparative sur 114 patients